The BBB gives it a B- and has flagged a pattern-of-complaints alert based on a review in April 2025 covering issues with consumers not receiving their medications and complaints about long phone wait times and unanswered messages
Severe loss of quality of life, due to symptoms such as debilitating fatigue, insomnia (B12 is required for synthesis of melatonin), mental illness, and neurological symptoms
It's only approved to treat type 2 diabetes, but people taking it do lose weight
November 7, 2022 Affecting over 40% of the United States population, obesity is a severe and widespread health condition
No regulatory authority Health Canada, the FDA, the EMA, the TGA, or any equivalent has cleared BPC-157 for therapeutic use in humans or animals
J Am Stat Assoc 83(403):596610 Acknowledgements The data used in this study was collected on 11/12/2024 from the TriNetX Research Network, which provided access to electronic medical records (diagnosis, procedures, medications, laboratory values, genomic information) from approximately 130 million patients from 120 healthcare organizations
